Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 156723
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Anti-inflammatory Therapeutics will have significant change from previous year. By the most conservative estimates of global Anti-inflammatory Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 95900 million in 2019. Over the next five years the Anti-inflammatory Therapeutics market will register a 6.3% CAGR in terms of revenue, the global market size will reach US$ 122620 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Others

On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-inflammatory Therapeutics Market Size 2016-2026

2.1.2 Anti-inflammatory Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Anti-inflammatory Therapeutics Segment by Type

2.2.1 Anti-inflammatory Biologics

2.2.2 Anti-inflammatory Biologics

2.2.3 Corticosteroids

2.2.4 Others

2.3 Anti-inflammatory Therapeutics Market Size by Type

2.3.1 Global Anti-inflammatory Therapeutics Market Size CAGR by Type

2.3.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

2.4 Anti-inflammatory Therapeutics Segment by Application

2.4.1 Arthritis

2.4.2 Respiratory Diseases

2.4.3 Dermatology

2.4.4 Gastroenterology

2.4.5 Others

2.5 Anti-inflammatory Therapeutics Market Size by Application

2.5.1 Global Anti-inflammatory Therapeutics Market Size CAGR by Application

2.5.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2016-2021)

3 Global Anti-inflammatory Therapeutics by Players

3.1 Anti-inflammatory Therapeutics Market Size Market Share by Players

3.1.1 Global Anti-inflammatory Therapeutics Revenue by Players (2019-2021E)

3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2019-2021E)

3.2 Global Anti-inflammatory Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Anti-inflammatory Therapeutics by Regions

4.1 Anti-inflammatory Therapeutics Market Size by Regions (2016-2021)

4.2 Americas Anti-inflammatory Therapeutics Market Size Growth (2016-2021)

4.3 APAC Anti-inflammatory Therapeutics Market Size Growth (2016-2021)

4.4 Europe Anti-inflammatory Therapeutics Market Size Growth (2016-2021)

4.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth (2016-2021)

5 Americas

5.1 Americas Anti-inflammatory Therapeutics Market Size by Country (2016-2021)

5.2 Americas Anti-inflammatory Therapeutics Market Size by Type (2016-2021)

5.3 Americas Anti-inflammatory Therapeutics Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-inflammatory Therapeutics Market Size by Region (2016-2021)

6.2 APAC Anti-inflammatory Therapeutics Market Size by Type (2016-2021)

6.3 APAC Anti-inflammatory Therapeutics Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Anti-inflammatory Therapeutics by Country (2016-2021)

7.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021)

7.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-inflammatory Therapeutics by Region (2016-2021)

8.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021)

8.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Anti-inflammatory Therapeutics Market Forecast

10.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2021-2026)

10.1.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2021-2026)

10.1.2 Americas Anti-inflammatory Therapeutics Forecast

10.1.3 APAC Anti-inflammatory Therapeutics Forecast

10.1.4 Europe Anti-inflammatory Therapeutics Forecast

10.1.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast

10.2 Americas Anti-inflammatory Therapeutics Forecast by Countries (2021-2026)

10.2.1 United States Anti-inflammatory Therapeutics Market Forecast

10.2.2 Canada Anti-inflammatory Therapeutics Market Forecast

10.2.3 Mexico Anti-inflammatory Therapeutics Market Forecast

10.2.4 Brazil Anti-inflammatory Therapeutics Market Forecast

10.3 APAC Anti-inflammatory Therapeutics Forecast by Region (2021-2026)

10.3.1 China Anti-inflammatory Therapeutics Market Forecast

10.3.2 Japan Anti-inflammatory Therapeutics Market Forecast

10.3.3 Korea Anti-inflammatory Therapeutics Market Forecast

10.3.4 Southeast Asia Anti-inflammatory Therapeutics Market Forecast

10.3.5 India Anti-inflammatory Therapeutics Market Forecast

10.3.6 Australia Anti-inflammatory Therapeutics Market Forecast

10.4 Europe Anti-inflammatory Therapeutics Forecast by Country (2021-2026)

10.4.1 Germany Anti-inflammatory Therapeutics Market Forecast

10.4.2 France Anti-inflammatory Therapeutics Market Forecast

10.4.3 UK Anti-inflammatory Therapeutics Market Forecast

10.4.4 Italy Anti-inflammatory Therapeutics Market Forecast

10.4.5 Russia Anti-inflammatory Therapeutics Market Forecast

10.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast by Region (2021-2026)

10.5.1 Egypt Anti-inflammatory Therapeutics Market Forecast

10.5.2 South Africa Anti-inflammatory Therapeutics Market Forecast

10.5.3 Israel Anti-inflammatory Therapeutics Market Forecast

10.5.4 Turkey Anti-inflammatory Therapeutics Market Forecast

10.5.5 GCC Countries Anti-inflammatory Therapeutics Market Forecast

10.6 Global Anti-inflammatory Therapeutics Forecast by Type (2021-2026)

10.8 Global Anti-inflammatory Therapeutics Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 AbbVie

11.1.1 AbbVie Company Information

11.1.2 AbbVie Anti-inflammatory Therapeutics Product Offered

11.1.3 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 AbbVie Main Business Overview

11.1.5 AbbVie Latest Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Offered

11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Johnson & Johnson Main Business Overview

11.2.5 Johnson & Johnson Latest Developments

11.3 Amgen Inc

11.3.1 Amgen Inc Company Information

11.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Offered

11.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Amgen Inc Main Business Overview

11.3.5 Amgen Inc Latest Developments

11.4 AstraZeneca PLC

11.4.1 AstraZeneca PLC Company Information

11.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered

11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 AstraZeneca PLC Main Business Overview

11.4.5 AstraZeneca PLC Latest Developments

11.5 Pfizer, Inc

11.5.1 Pfizer, Inc Company Information

11.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Offered

11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Pfizer, Inc Main Business Overview

11.5.5 Pfizer, Inc Latest Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Anti-inflammatory Therapeutics Product Offered

11.6.3 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Novartis Main Business Overview

11.6.5 Novartis Latest Developments

11.7 Roche

11.7.1 Roche Company Information

11.7.2 Roche Anti-inflammatory Therapeutics Product Offered

11.7.3 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Roche Main Business Overview

11.7.5 Roche Latest Developments

11.8 Merck

11.8.1 Merck Company Information

11.8.2 Merck Anti-inflammatory Therapeutics Product Offered

11.8.3 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Merck Main Business Overview

11.8.5 Merck Latest Developments

11.9 Sanofi

11.9.1 Sanofi Company Information

11.9.2 Sanofi Anti-inflammatory Therapeutics Product Offered

11.9.3 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Sanofi Main Business Overview

11.9.5 Sanofi Latest Developments

11.10 GlaxoSmithKline

11.10.1 GlaxoSmithKline Company Information

11.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered

11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 GlaxoSmithKline Main Business Overview

11.10.5 GlaxoSmithKline Latest Developments

11. Sun Pharmaceutical Industries Ltd

11.11.1 Sun Pharmaceutical Industries Ltd Company Information

11.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered

11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview

11.11.5 Sun Pharmaceutical Industries Ltd Latest Developments

11.12 TEVA

11.12.1 TEVA Company Information

11.12.2 TEVA Anti-inflammatory Therapeutics Product Offered

11.12.3 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 TEVA Main Business Overview

11.12.5 TEVA Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Anti-inflammatory Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Anti-inflammatory Biologics

Table 3. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Table 4. Major Players of Corticosteroids

Table 5. Major Players of Others

Table 6. Anti-inflammatory Therapeutics Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 7. Global Anti-inflammatory Therapeutics Market Size by Type (2016-2021) & ($ Millions)

Table 8. Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

Table 9. Anti-inflammatory Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 10. Global Anti-inflammatory Therapeutics Market Size by Application (2016-2021) & ($ Millions)

Table 11. Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2016-2021)

Table 12. Global Anti-inflammatory Therapeutics Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2019-2021E)

Table 14. Global Anti-inflammatory Therapeutics Key Players Head office and Products Offered

Table 15. Anti-inflammatory Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Anti-inflammatory Therapeutics Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions 2016-2021

Table 20. Americas Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Anti-inflammatory Therapeutics Market Size Market Share by Country (2016-2021)

Table 22. Americas Anti-inflammatory Therapeutics Market Size by Type (2016-2021) & ($ Millions)

Table 23. Americas Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

Table 24. Americas Anti-inflammatory Therapeutics Market Size by Application (2016-2021) & ($ Millions)

Table 25. Americas Anti-inflammatory Therapeutics Market Size Market Share by Application (2016-2021)

Table 26. APAC Anti-inflammatory Therapeutics Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Anti-inflammatory Therapeutics Market Size Market Share by Region (2016-2021)

Table 28. APAC Anti-inflammatory Therapeutics Market Size by Type (2016-2021) & ($ Millions)

Table 29. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

Table 30. APAC Anti-inflammatory Therapeutics Market Size by Application (2016-2021) & ($ Millions)

Table 31. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application (2016-2021)

Table 32. Europe Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Anti-inflammatory Therapeutics Market Size Market Share by Country (2016-2021)

Table 34. Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021) & ($ Millions)

Table 35. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

Table 36. Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021) & ($ Millions)

Table 37. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2016-2021)

Table 38. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

Table 42. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2016-2021)

Table 44. Key and Potential Regions of Anti-inflammatory Therapeutics

Table 45. Key Application and Potential Industries of Anti-inflammatory Therapeutics

Table 46. Key Challenges of Anti-inflammatory Therapeutics

Table 47. Key Trends of Anti-inflammatory Therapeutics

Table 48. Global Anti-inflammatory Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Regions

Table 50. Global Anti-inflammatory Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 51. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Type (2021-2026)

Table 52. Global Anti-inflammatory Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 53. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Application (2021-2026)

Table 54. AbbVie Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 55. AbbVie Anti-inflammatory Therapeutics Product Offered

Table 56. AbbVie Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. AbbVie Main Business

Table 58. AbbVie Latest Developments

Table 59. Johnson & Johnson Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 60. Johnson & Johnson Anti-inflammatory Therapeutics Product Offered

Table 61. Johnson & Johnson Main Business

Table 62. Johnson & Johnson Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. Johnson & Johnson Latest Developments

Table 64. Amgen Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 65. Amgen Inc Anti-inflammatory Therapeutics Product Offered

Table 66. Amgen Inc Main Business

Table 67. Amgen Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. Amgen Inc Latest Developments

Table 69. AstraZeneca PLC Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 70. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered

Table 71. AstraZeneca PLC Main Business

Table 72. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. AstraZeneca PLC Latest Developments

Table 74. Pfizer, Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 75. Pfizer, Inc Anti-inflammatory Therapeutics Product Offered

Table 76. Pfizer, Inc Main Business

Table 77. Pfizer, Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. Pfizer, Inc Latest Developments

Table 79. Novartis Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 80. Novartis Anti-inflammatory Therapeutics Product Offered

Table 81. Novartis Main Business

Table 82. Novartis Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. Novartis Latest Developments

Table 84. Roche Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 85. Roche Anti-inflammatory Therapeutics Product Offered

Table 86. Roche Main Business

Table 87. Roche Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. Roche Latest Developments

Table 89. Merck Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 90. Merck Anti-inflammatory Therapeutics Product Offered

Table 91. Merck Main Business

Table 92. Merck Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. Merck Latest Developments

Table 94. Sanofi Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 95. Sanofi Anti-inflammatory Therapeutics Product Offered

Table 96. Sanofi Main Business

Table 97. Sanofi Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. Sanofi Latest Developments

Table 99. GlaxoSmithKline Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 100. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered

Table 101. GlaxoSmithKline Main Business

Table 102. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. GlaxoSmithKline Latest Developments

Table 104. Sun Pharmaceutical Industries Ltd Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 105. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered

Table 106. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 107. Sun Pharmaceutical Industries Ltd Main Business

Table 108. Sun Pharmaceutical Industries Ltd Latest Developments

Table 109. TEVA Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors

Table 110. TEVA Anti-inflammatory Therapeutics Product Offered

Table 111. TEVA Main Business

Table 112. TEVA Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 113. TEVA Latest Developments

List of Figures

Figure 1. Anti-inflammatory Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Anti-inflammatory Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2016-2021)

Figure 7. Anti-inflammatory Therapeutics in Arthritis

Figure 8. Global Anti-inflammatory Therapeutics Market: Arthritis (2016-2021) & ($ Millions)

Figure 9. Anti-inflammatory Therapeutics in Respiratory Diseases

Figure 10. Global Anti-inflammatory Therapeutics Market: Respiratory Diseases (2016-2021) & ($ Millions)

Figure 11. Anti-inflammatory Therapeutics in Dermatology

Figure 12. Global Anti-inflammatory Therapeutics Market: Dermatology (2016-2021) & ($ Millions)

Figure 13. Anti-inflammatory Therapeutics in Gastroenterology

Figure 14. Global Anti-inflammatory Therapeutics Market: Gastroenterology (2016-2021) & ($ Millions)

Figure 15. Anti-inflammatory Therapeutics in Others

Figure 16. Global Anti-inflammatory Therapeutics Market: Others (2016-2021) & ($ Millions)

Figure 17. Global Anti-inflammatory Therapeutics Market Size Market Share by Application in 2020

Figure 18. Global Anti-inflammatory Therapeutics Revenue Market Share by Player in 2020

Figure 19. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Anti-inflammatory Therapeutics Market Size 2016-2021 ($ Millions)

Figure 21. APAC Anti-inflammatory Therapeutics Market Size 2016-2021 ($ Millions)

Figure 22. Europe Anti-inflammatory Therapeutics Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Anti-inflammatory Therapeutics Market Size 2016-2021 ($ Millions)

Figure 24. Americas Anti-inflammatory Therapeutics Market Size Market Share by Country in 2020

Figure 25. Americas Anti-inflammatory Therapeutics Market Size Market Share by Type in 2020

Figure 26. Americas Anti-inflammatory Therapeutics Market Size Market Share by Application in 2020

Figure 27. United States Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Anti-inflammatory Therapeutics Market Size Market Share by Regions in 2020

Figure 31. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type in 2020

Figure 32. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application in 2020

Figure 33. China Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Anti-inflammatory Therapeutics Market Size Market Share by Countries in 2020

Figure 40. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type in 2020

Figure 41. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application in 2020

Figure 42. Germany Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application in 2020

Figure 50. Egypt Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Countries Anti-inflammatory Therapeutics Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 56. APAC Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 57. Europe Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 59. United States Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 60. Canada Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 63. China Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 64. Japan Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 65. Korea Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 67. India Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 68. Australia Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 69. Germany Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 70. France Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 71. UK Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 72. Italy Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 73. Russia Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 74. Spain Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 77. Israel Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)

Figure 79. GCC Countries Anti-inflammatory Therapeutics Market Size 2021-2026 ($ Millions)